Perfection is not attainable, but if we chase perfection we can catch excellence.
perfection we can catch excellence. SF has been reported in nearly all bare metal stents (BMS) and drug-eluting stents (DES), and the reported rates vary widely by scaffold type, and are contingent upon the rigor with which investigators have sought out this complication. In a meta-analysis of 8 studies (n ¼ 5,321 patients; 108 SF) within <12 months follow-up after DES implantation, the mean reported incidence of SF was 4.0% (95% confidence interval
[CI]: 0.4% to 16.3%) (6) . Consistent with prior observations, the probability of SF was highest in right coronary arteries, lesions with overlapping stents, and longer stents (average length: 46 mm; 95% CI: 38 to 54 mm). Lesions with stent fractures had a higher rate of ISR (38% vs. 8.2%, respectively; p < 0.0001) as well as a higher rate of TLR (17% vs. 5.6%, respectively; p < 0.0001). Repeat angiography and procedures were generally clinically driven, creating a bias toward an overestimation of SF when judged as a proportion of only the population of patients who received repeat angiography. However, even in this selected population, all cases of SF may not have been captured due to short follow-up and limited use of invasive coronary imaging. Standard fluoroscopic angiography detection may be insensitive to definite SF, as a 29% rate of SF has been seen at autopsy, using high-contrast filmbased radiography of explanted coronaries (7). Given the above evidence, one might reasonably conclude that SF increases ISR, TLR, morbidity, and mortality.
However, a reliable association with major adverse cardiac events (MACE) has yet to be published in an unselected population that has been assiduously followed for SF after initial DES implantation. Furthermore, the high incidence of SF, often devoid of associated pathology at autopsy, suggests that SF remains clinically silent in most patients.
In this issue of JACC: Cardiovascular Interventions, research support from Infraredx, Inc. Dr. Giri has reported that he has no relationships relevant to the contents of this paper to disclose. Through delving deeply into the overlooked phenomenon of coronary SF, the current study represents another step on this journey. Although perfection may never be realized, there is no question that the operators of 2 decades ago would consider the current state of our field to be excellent.
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